What Researchers Did
The researchers reviewed published studies on treatments for brain radiation necrosis, a type of brain tissue damage that can follow stereotactic radiosurgery, in patients whose symptoms did not respond to corticosteroids.
What They Found
This systematic review of 21 articles, only 2 of them prospective, pooled results for bevacizumab, laser interstitial thermal therapy (LITT), and surgery, and found symptom or imaging improvement or stability in most patients for each. Bevacizumab had a pooled symptom improvement or stability rate of 86% (95% CI 77% to 92%). LITT had a pooled T1 postcontrast improvement or stability rate of 88%, and surgery had a pooled symptom improvement or stability rate of 89%. Only 1 report was relevant for hyperbaric oxygen therapy, and the abstract gives no pooled result for it. Toxicity was inconsistently reported but was generally low for all treatments. The authors did not directly compare the treatments with each other.
What This Means for Canadian Patients
For corticosteroid-refractory radiation necrosis that does not need urgent surgery, the authors strongly recommend bevacizumab in carefully selected patients. The abstract does not make a recommendation about hyperbaric oxygen therapy and reports no results for it. Anyone dealing with radiation necrosis should discuss the options with their treating team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The authors state that the overall evidence for each treatment is of low quality, most included studies were not prospective, toxicity was inconsistently reported, and the treatments were not directly compared.